Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients

被引:28
作者
Choi, Young Sik
Ku, Seung-Yup
Jee, Byung-Chul
Suh, Chang-Suk
Choi, Young Min
Kim, Jung Gu
Moon, Shin Yong
Kim, Seok Hyun
机构
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Med Res Ctr, Inst Reprod Med & Populat, Seoul 110744, South Korea
关键词
GnRH agonist and antagonist; IGF; IGFBP; IVF-embryo transfer; PAPP-A;
D O I
10.1093/humrep/del091
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Insulin-like growth factors (IGF) and their binding proteins (IGFBP) play a major role in the autocrine and paracrine regulation of folliculogenesis. This is the first study that has compared follicular fluid (FF) IGF-I, IGF-II, IGFBP-3, IGFBP-4 and pregnancy-associated plasma protein (PAPP)-A concentrations, and their ratios, to investigate whether there was any difference in the intrafollicular microenvironment between the GnRH agonist (GnRHa) and antagonist (GnRHant) protocols for controlled ovarian stimulation (COS). METHODS: A total of 68 IVF cycles were included in this study; two groups were studied: GnRHa long protocol group (n = 36) and the flexible GnRHant multiple-dose protocol group (n = 32). FF was obtained from dominant follicles during oocyte retrieval and stored at -70 degrees C until assayed. IGF-I, IGF-II and IGFBP-3 concentrations were measured by radioimmunoassay and IGFBP-4 and PAPP-A by enzyme-linked immunosorbent assay. RESULTS: The duration of COS was significantly longer, and total dose of gonadotrophins used, serum estradiol (E-2) levels on hCG day and the number of oocytes retrieved were significantly higher in the GnRHa long protocol group. The concentrations of FF IGF-II and IGFBP-4 were significantly higher, and the ratio of IGF-I/IGFBP-4 was significantly lower in the GnRHa long protocol group. Serum E-2 levels per mature follicle were not different between the two groups. CONCLUSIONS: Our data may indicate a difference of intrafollicular microenvironment between cycles using GnRHa long protocols and those using GnRHant protocols. However, the difference in microenvironment does not appear to result in a difference in clinical outcome.
引用
收藏
页码:2015 / 2021
页数:7
相关论文
共 43 条
  • [1] Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary
    Agarwal, SK
    Vogel, K
    Weitsman, SR
    Magoffin, DA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) : 1072 - 1076
  • [2] GnRH antagonist in assisted reproduction: a Cochrane review
    Al-Inany, H
    Aboulghar, M
    [J]. HUMAN REPRODUCTION, 2002, 17 (04) : 874 - 885
  • [3] Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin
    Albano, C
    Felberbaum, RE
    Smitz, J
    Riethmüller-Winzen, H
    Engel, J
    Diedrich, K
    Devroey, P
    [J]. HUMAN REPRODUCTION, 2000, 15 (03) : 526 - 531
  • [4] Gonadotropin releasing hormone (GnRH) antagonist (cetrorelix) versus GnRH agonist treatment - an age and gonadotropin matched study in young normal responders
    Berger, BM
    Ezcurra, D
    Alper, MM
    [J]. FERTILITY AND STERILITY, 2004, 82 : S235 - S236
  • [5] Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles
    Brus, L
    Lambalk, CB
    deKoning, J
    Helder, MN
    Janssens, RMJ
    Schoemaker, J
    [J]. HUMAN REPRODUCTION, 1997, 12 (04) : 769 - 773
  • [6] Recombinant FSH and pregnancy-associated plasma protein
    Choi, D
    Hwang, SS
    Lee, EY
    Park, CE
    Yoon, BK
    Lee, JH
    Bae, DS
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 109 (02) : 171 - 176
  • [7] Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A
    Conover, CA
    Oxvig, C
    Overgaard, MT
    Christiansen, M
    Giudice, LC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) : 4742 - 4745
  • [8] Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)
    de Jong, D
    Macklon, NS
    Eijkemans, MJC
    Mannaerts, BMJL
    Bennink, HJTC
    Fauser, BCJM
    [J]. FERTILITY AND STERILITY, 2001, 75 (04) : 688 - 693
  • [9] SUPPRESSION OF THE ENDOGENOUS LUTEINIZING-HORMONE SURGE BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX DURING OVARIAN STIMULATION
    DIEDRICH, K
    DIEDRICH, C
    SANTOS, E
    ZOLL, C
    ALHASANI, S
    REISSMANN, T
    KREBS, D
    KLINGMULLER, D
    [J]. HUMAN REPRODUCTION, 1994, 9 (05) : 788 - 791
  • [10] In controlled ovarian hyperstimulation, steroid production, oocyte retrieval, and pregnancy rate correlate with gene expression of vascular endothelial growth factor
    Doldi, N
    Bassan, M
    Fusi, FM
    Ferrari, A
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1997, 14 (10) : 589 - 592